首页|0.25%罗哌卡因用于超声引导颈中间丛阻滞的有效容量探讨

0.25%罗哌卡因用于超声引导颈中间丛阻滞的有效容量探讨

扫码查看
目的 探索0。25%罗哌卡因用于超声引导颈中间丛阻滞的半数有效容量和95%有效容量。方法 选择 29 例行择期颈部手术的患者,均在超声引导下进行 0。25%罗哌卡因颈中间丛阻滞,若颈丛分支所属皮区痛觉均消失,则视为完全阻滞(完全阻滞组,14例),否则视为不完全阻滞(不完全阻滞组,15 例)。记录阻滞效果,分析 0。25%罗哌卡因用于超声引导颈中间丛阻滞的有效容量;比较完全阻滞组和不完全阻滞组患者的一般特征、罗哌卡因阻滞容量、并发症发生情况及阻滞前后深吸气膈肌移动度。结果 0。25%罗哌卡因用于超声引导颈中间丛阻滞的半数有效容量为 10。3 ml[95%可信区间(CI)=(7。7,13。5)ml],95%有效容量为 15。6 ml[95%CI=(12。8,44。0)ml]。完全阻滞组和不完全阻滞组年龄、性别、美国麻醉医师协会(ASA)分级、身高、体重及体质量指数(BMI)比较差异无统计学意义(P>0。05)。完全阻滞组用罗哌卡因容量(11。1±2。0)ml显著高于不完全阻滞组的(9。2±2。0)ml,差异有统计学意义(P<0。05)。不完全阻滞组与完全阻滞组阻滞前深吸气膈肌移动度分别为(4。17±0。87)、(4。09±0。85)cm,比较差异无统计学意义(P>0。05);不完全阻滞组与完全阻滞组阻滞后深吸气膈肌移动度分别为(4。09±0。85)、(3。99±0。70)cm,比较差异无统计学意义(P>0。05)。完全阻滞组 1 例患者发生声音嘶哑,其给药容量为 14 ml;其余所有患者均未发生膈神经阻滞、迷走神经阻滞、局部麻醉药物中毒、Horner征或低氧血症等情况。结论 0。25%罗哌卡因用于超声引导颈中间丛阻滞的半数有效容量为 10。3 ml[95%CI=(7。7,13。5)ml],95%有效容量为 15。6 ml[95%CI=(12。8,44。0)ml]。
Effective volume of 0.25%ropivacaine in ultrasound-guided intermediate cervical plexus block
Objective To investigate the effective volumes(EV)of 0.25%ropivacaine in ultrasound-guided intermediate cervical plexus block,specifically the 50%effective volume and the 95%effective volume.Methods 29 patients who underwent elective neck surgery and were selected,and 0.25%ropivacaine was used for ultrasound-guided intermediate cervical plexus block;if all the nociceptive sensations in the dermatomes belonging to the branches of the cervical plexus disappeared,it was regarded as a complete block(complete block group,14 cases);otherwise,it was regarded as an incomplete block(incomplete block group,15 cases).The block effect was recorded,and the effective volume of 0.25%ropivacaine used for ultrasound-guided intermediate cervical plexus block was analyzed;the general characteristics,volume of ropivacaine,occurrence of complications,and diaphragm excursion during deep breathing before and after block were compared between the complete block group and the incomplete block group.Results The 50%effective volume for ultrasound-guided intermediate cervical plexus block with 0.25%ropivacaine was found to be 10.3 ml[95%confidence interval(CI)=(7.7,13.5)ml],while the 95%effective volume was determined to be 15.6 ml[95%CI=(12.8,44.0)ml].There were no significant differences in age,gender,American Society of Anesthesiologists(ASA)grade,height,weight and body mass index(BMI)between the complete block group and the incomplete block group(P>0.05).The volume of ropivacaine in the complete block group was(11.1±2.0)ml,which was significantly higher than(9.2±2.0)ml in the incomplete block group,and the difference was statistically significant(P<0.05).Before block,the diaphragm excursion during deep breathing in incomplete block group and complete block group were(4.17±0.87)and(4.09±0.85)cm,and the difference was not statistically significant in comparison(P>0.05).After block,the diaphragm excursion during deep breathing in incomplete block group and complete block group were(4.09±0.85)and(3.99±0.70)cm,and the difference was not statistically significant in comparison(P>0.05).Among the patients with complete blocks,one developed hoarseness,whose administered volume was 14 ml,but there were no occurrences of phrenic nerve block,vagus nerve block,local anesthetic drug toxicity,Horner's sign,or hypoxemia in the remaining patients.Conclusion The 50%effective volume of 0.25%ropivacaine for ultrasound-guided intermediate cervical plexus block is 10.3 ml[95%CI=(7.7,13.5)ml],while the 95%effective volume is 15.6 ml[95%CI=(12.8,44.0)ml].

Intermediate cervical plexus blockRopivacaineEffective volumeDixon's sequential method

陈晓影、蒋俊丹、龚灿生、郑晓春

展开 >

350012 福建省立医院,福建医科大学省立临床医学院麻醉科

350012 福建省急救中心,福建省急诊医学重点实验室,福建省疑难重症研究重点实验室

颈中间丛阻滞 罗哌卡因 有效容量 Dixon序贯法

福建省自然科学基金

2022J011009

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(8)
  • 17